Financings in Brief: LifeCell
This article was originally published in The Gray Sheet
Executive Summary
LifeCell: Woodlands, Texas-based firm files with the SEC for a secondary offering of 4.5 mil. shares of common stock -- including 4 mil. to be sold by the company and 500,000 to be sold by selling shareholders. LifeCell will use net proceeds for further development, sales and marketing of its AlloDerm dermal tissue graft product, as well as for working capital and general corporate purposes. Vector Securities International and Gruntal & Co., LLC are underwriters for the offering...